Legal & General Group
DSCI

Legal & General Group’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Legal & General Group’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,160
Closed -$36K – 2839
2015
Q1 		$36K Hold
4,160
– – ﹤0.01% 2626
2014
Q4 		$38K Hold
4,160
– – ﹤0.01% 2554
2014
Q3 		$35K Buy
+4,160
New +$38.5K ﹤0.01% 2543

Other funds holding DSCI

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Legal & General Group's DSCI Position: Q2 2015 in Review

Legal & General Group sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2015, closing a stake of 4,160 shares — an estimated $36K sold.

Legal & General Group first reported a position in DSCI in Q3 2014 and held it in 3 quarters. The position peaked at $38K in Q4 2014. 62 funds tracked by Wall St. Rank hold DSCI as of Q2 2015.

  • Legal & General Group reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2015 after selling out during the quarter.
  • Legal & General Group sold 4,160 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2015, an estimated $36K.
  • Legal & General Group first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q3 2014 and held it in 3 quarters.
  • Legal & General Group's Derma Sciences, Inc. Common Stock (DE) position peaked at $38K in Q4 2014.
  • 62 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2015.

Based on Legal & General Group's 13F filing for Q2 2015, filed 31 Jul 2015.